Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma

Cellular Immunology

Volumn 295, Issue 1, 2015, Pages 29-35

  Dolen, Yusuf ^a   Gunaydin, Gurcan ^a   Esendagli, Gunes ^a   Guc, Dicle ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Granulocyte; MDSC; Myeloid derived suppressor cells; Rat

Indexed keywords

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; BONE MARROW CELL; BREAST CARCINOMA; CD4+ T LYMPHOCYTE; CELL COUNT; CELL EXPANSION; CELL POPULATION; FEMALE; GIEMSA STAIN; GRANULOCYTE; HELPER CELL; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; SPLEEN; SPLEEN CELL; SUPPRESSOR CELL; ANIMAL; CELL CULTURE; CELL PROLIFERATION; EXPERIMENTAL MAMMARY NEOPLASM; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MONOCYTE; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

IMMUNOGLOBULIN RECEPTOR; PTPNS1 PROTEIN, RAT;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; IMMUNOPHENOTYPING; MAMMARY NEOPLASMS, ANIMAL; MONOCYTES; MYELOID CELLS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84923327005     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.02.005     Document Type: Article

References (29)

1. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
2. Diaz-Montero C.M., Salem M.L., Nishimura M.I., Garrett-Mayer E., Cole D.J., Montero A.J. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother.: CII 2009, 58:49-59.
3. Otsuji M., Kimura Y., Aoe T., Okamoto Y., Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:13119-13124.
4. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008, 181:5791-5802.
5. Youn J.I., Collazo M., Shalova I.N., Biswas S.K., Gabrilovich D.I. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 2012, 91:167-181.
6. Youn J.I., Kumar V., Collazo M., Nefedova Y., Condamine T., Cheng P., Villagra A., Antonia S., McCaffrey J.C., Fishman M., Sarnaik A., Horna P., Sotomayor E., Gabrilovich D.I. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat. Immunol. 2013, 14:211-220.
7. Youn J.I., Gabrilovich D.I. New roles of Rb1 in expansion of MDSCs in cancer. Cell Cycle 2013, 12:1329-1330.
8. Prins R.M., Scott G.P., Merchant R.E., Graf M.R. Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression. Cancer Immunol. Immunother.: CII 2002, 51:190-199.
9. Ghiringhelli F., Puig P.E., Roux S., Parcellier A., Schmitt E., Solary E., Kroemer G., Martin F., Chauffert B., Zitvogel L. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 2005, 202:919-929.
10. Dugast A.S., Haudebourg T., Coulon F., Heslan M., Haspot F., Poirier N., Vuillefroy de Silly R., Usal C., Smit H., Martinet B., Thebault P., Renaudin K., Vanhove B. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol. 2008, 180:7898-7906.
11. Jia W., Jackson-Cook C., Graf M.R. Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model. J. Neuroimmunol. 2010, 223:20-30.
12. Zhang C., Lei G.S., Shao S., Jung H.W., Durant P.J., Lee C.H. Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infect. Immun. 2012, 80:3634-3641.
13. Thompson H.J., Adlakha H. Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res. 1991, 51:3411-3415.
14. Esendagli G., Yilmaz G., Canpinar H., Gunel-Ozcan A., Guc M.O., Guc D. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats. Lab. Anim. 2009, 43:60-64.
15. Ysebaert D.K., De Greef K.E., Vercauteren S.R., Ghielli M., Verpooten G.A., Eyskens E.J., De Broe M.E. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol. Dialysis Transplant. 2000, 15:1562-1574.
16. Gotoh S., Itoh M., Fujii Y., Arai S., Sendo F. Enhancement of the expression of a rat neutrophil-specific cell surface antigen by activation with phorbol myristate acetate and concanavalin A. J. Immunol. 1986, 137:643-650.
17. Yrlid U., Jenkins C.D., MacPherson G.G. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J. Immunol. 2006, 176:4155-4162.
18. Perse M., Cerar A., Injac R., Strukelj B. N-methylnitrosourea induced breast cancer in rat, the histopathology of the resulting tumours and its drawbacks as a model. Pathol. Oncol. Res.: POR 2009, 15:115-121.
19. Fahmi T., Esendagli G., Yilmaz G., Kansu E., Guc D. Immune compartmentalization of T cell subsets in chemically-induced breast cancer. Scand. J. Immunol. 2010, 72:339-348.
20. Esendagli G., Canpinar G., Yilmaz G., Gunel-Ozcan A., Guc M.O., Kansu E., Guc D. Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene. Cancer Biol. Ther. 2009, 8:136-142.
21. Bronte V., Serafini P., De Santo C., Marigo I., Tosello V., Mazzoni A., Segal D.M., Staib C., Lowel M., Sutter G., Colombo M.P., Zanovello P. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 2003, 170:270-278.
22. Sinha P., Clements V.K., Bunt S.K., Albelda S.M., Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 2007, 179:977-983.
23. Lu Y.Q., Gu L.H., Zhang Q., Jiang J.K., Mou H.Z. Hypertonic saline resuscitation contributes to early accumulation of circulating myeloid-derived suppressor cells in a rat model of hemorrhagic shock. Chin. Med. J. 2013, 126:1317-1322.
24. Rotondo R., Bertolotto M., Barisione G., Astigiano S., Mandruzzato S., Ottonello L., Dallegri F., Bronte V., Ferrini S., Barbieri O. Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J. Leukoc. Biol. 2011, 89:721-727.
25. Ahuja V., Miller S.E., Howell D.N. Identification of two subpopulations of rat monocytes expressing disparate molecular forms and quantities of CD43. Cell. Immunol. 1995, 163:59-69.
26. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J., Liu Y.J., MacPherson G., Randolph G.J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J.M., Lutz M.B. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
27. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., Aikawa E., Mempel T.R., Libby P., Weissleder R., Pittet M.J. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
28. Mirza N., Gabrilovich D. Comment on "Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells". J. Immunol. 2007, 178:4705-4706. author reply 4706.
29. Attwood J.T., Munn D.H. Macrophage suppression of T cell activation: a potential mechanism of peripheral tolerance. Int. Rev. Immunol. 1999, 18:515-525.